ERBB2 and inflammatory breast carcinoma: The patient SKM00447 was metastatic inflammatory breast cancer with estrogen receptor (ER)-positive, progesterone receptor (PR)-negative, and HER2/neu-negative treated with multiple lines of systemic therapy, including endocrine therapy and combination chemotherapy.